Non-Seasonally Depressed :: Health-Informant.com :: http://www.health-informant.com

Current articles and info about your health

Monday, 13th October 2008

home about authors news books xml feed sitemap privacy contact us

There are 7 users online

add to favorites

make home page

Addiction Issues
Aging
Allergies & Sinuses
Alternative Medicine
Beauty & Health
Books & Reading
Common Illnesses
Community Service
Diabetic Health
Dieting
Diseases
Environmental Health
Exercise and Fitness
Health Education
Health Industry
Health Insurance
Health Legal Issues
Health Technology
Healthcare Services
Healthy Eating
Medical Equipment & Products
Men's Health
Mental and Emotional Health
Muscle & Back Pain
Nutrition and Supplements
Pediatrics
Pet Health
Physical Therapy & Massage
Prevention Health
Vision Health
Weight Management
Women's Health

Our Newsletter

Other Resources

For other sources of health news, tips, and information, visit our resources page

Submit an Article

Would you like to have your article posted? Click Here

Non-Seasonally Depressed
Added: 12/17/2003 Type: Summary Viewed: 1011 time(s) [ Not Rated Yet ]

How would you rate this article: Bad Good Go ť

Printer Friendly Version

Non-Seasonally Depressed

Light therapy is normally used for winter depression. But in a pioneering research study published in the June 2003 issue of the Journal of Clinical Psychiatry, a Canadian-developed light therapy technology dramatically reduced the normal delay in the response time of non-seasonally depressed patients to Celexa, a popular Selective Seratonin Reuptake Inhibitor (SSRI) antidepressant medication.

The study's findings are "likely to change common clinical practice" for treating major depression if further confirmed, stated lead researcher Dr. Francesco Benedetti at the fall meeting of the European College of Neuropsychopharmacology. As the research team concluded, properly timed low-intensity light therapy provides a "new effective augmenting strategy" for treating depression with SSRIs.

The controlled study conducted in Milan, Italy examined the effects of pairing a low-intensity light therapy device developed by Sunnex Biotechnologies with the Celexa. Dr. Benedetti's team found that when patients were treated with Sunnex Biotechnologies' low-intensity light therapy along with Celexa, they responded to the medication within only three days of initiating treatment. This speed of response marked a substantial improvement over the two-to-four weeks typically required for people to respond to SSRI antidepressants.

SSRIs are the most popular class of antidepressant medication in North America. But a major problem with SSRIs is the long time lag before they begin to work. This research team found that "synergistic effects of light and drugs" allow patients to recover from depression faster than with SSRI medication alone.

Light therapy not only helped the Celexa kick in faster, but also to obtain better results in patients throughout the four-week study. There was overall "better mood improvement in (Sunnex) light-treated patients" with a treatment strategy that was "devoid of side effects," according to the published paper. Over half of the patients treated with Celexa and Sunnex light therapy fully recovered from their depression after two weeks, and more than three-quarters were no longer ill by the end of the four-week study. In contrast, fewer than half of the patients treated with Celexa and a placebo recovered even after four weeks.

In 1995, Sunnex Biotechnologies patented its low-intensity Lo-LIGHT therapy lamp to provide light therapy that eliminates common side effects accompanying bright light therapy, including discomfort and the risk of retinal damage. Through careful selection of wavelengths, the Sunnex technology restricts the intensity of light therapy to a level of light normally found indoors.

Article Pages: 1

Article Comments

Add Comment |

View All (0)

There are currently no comments for this article.

Advanced Search


Good Resources
Create a Happier Life Diabetes Diet Affiliate With Us